Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InductOs in Open Diaphyseal Tibia Fractures
NCT00161616Phase 4Completed
- Sponsor
- Pfizer
- Start
- Sep 2003
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
Phase 4, randomised, open-label trial in Tibial Fracture comparing InductOs with Standard of Care (2 arms). Primary endpoint: Number of Patients With Healed Fractures at 20 weeks. Started Sep 2003; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
Tibial Fracture
Beyond the preview
Go deeper on NCT00161616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161616.